Focus Partners Wealth Trims Stock Position in Cardinal Health, Inc. $CAH

Focus Partners Wealth cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,952 shares of the company’s stock after selling 245 shares during the quarter. Focus Partners Wealth’s holdings in Cardinal Health were worth $2,473,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. increased its holdings in Cardinal Health by 5.3% during the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after buying an additional 15,956 shares during the period. Kingswood Wealth Advisors LLC increased its holdings in Cardinal Health by 17.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock valued at $429,000 after buying an additional 457 shares during the period. Assenagon Asset Management S.A. boosted its stake in Cardinal Health by 25.8% in the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock valued at $1,811,000 after acquiring an additional 2,694 shares in the last quarter. Golden State Wealth Management LLC boosted its stake in Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock valued at $54,000 after acquiring an additional 336 shares in the last quarter. Finally, North Capital Inc. acquired a new stake in Cardinal Health in the first quarter valued at approximately $83,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.09% of the stock is currently owned by corporate insiders.

Cardinal Health Price Performance

NYSE:CAH opened at $150.45 on Tuesday. The firm has a market capitalization of $35.93 billion, a price-to-earnings ratio of 23.33, a PEG ratio of 1.29 and a beta of 0.73. The company’s 50-day moving average is $154.16 and its two-hundred day moving average is $148.08. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health’s dividend payout ratio is 31.63%.

Analysts Set New Price Targets

Several brokerages have weighed in on CAH. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Evercore ISI lowered their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Finally, UBS Group restated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.